Survival of patients undergoing Nd: YAG laser therapy compared with Nd:YAG laser therapy and brachytherapy for malignant airway disease

J. M. Shea, Roblee P Allen, R. S. Tharratt, Andrew Chan, A. D. Siefkin

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Brachytherapy in combination with Nd:YAG laser therapy may add to the duration of survival of the palliative period when compared with laser alone. A retrospective study of patients with inoperable squamous cell carcinoma (SCC) was undertaken to determine if there was a difference in survival between those patients treated with Nd:YAG laser alone and those treated with Nd:YAG laser and brachytherapy. Twenty-two patients were treated with brachytherapy for malignant airway disease at our institution of which 13 had SCC. All patients had previously received treatment with Nd:YAG laser for exophytic disease. Survival was compared with those patients treated with Nd:YAG laser alone for SCC involving the airway. There was no statistical difference between the two groups with regard to age. The duration of survival of patients with SCC of the airway from the first Nd:YAG laser treatment was determined. A significant difference between those patients treated with Nd:YAG laser alone and those patients treated with combined therapy was found (p<0.001). Brachytherapy may potentiate the duration of survival in patients with SCC involving the airway compared to palliation with Nd:YAG laser alone.

Original languageEnglish (US)
Pages (from-to)1028-1031
Number of pages4
JournalChest
Volume103
Issue number4
StatePublished - 1993
Externally publishedYes

Fingerprint

Solid-State Lasers
Brachytherapy
Laser Therapy
Survival
Squamous Cell Carcinoma
Lasers
Therapeutics
Retrospective Studies

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Survival of patients undergoing Nd : YAG laser therapy compared with Nd:YAG laser therapy and brachytherapy for malignant airway disease. / Shea, J. M.; Allen, Roblee P; Tharratt, R. S.; Chan, Andrew; Siefkin, A. D.

In: Chest, Vol. 103, No. 4, 1993, p. 1028-1031.

Research output: Contribution to journalArticle

@article{7bc1d0ebace24ac0983fa53b92fd419f,
title = "Survival of patients undergoing Nd: YAG laser therapy compared with Nd:YAG laser therapy and brachytherapy for malignant airway disease",
abstract = "Brachytherapy in combination with Nd:YAG laser therapy may add to the duration of survival of the palliative period when compared with laser alone. A retrospective study of patients with inoperable squamous cell carcinoma (SCC) was undertaken to determine if there was a difference in survival between those patients treated with Nd:YAG laser alone and those treated with Nd:YAG laser and brachytherapy. Twenty-two patients were treated with brachytherapy for malignant airway disease at our institution of which 13 had SCC. All patients had previously received treatment with Nd:YAG laser for exophytic disease. Survival was compared with those patients treated with Nd:YAG laser alone for SCC involving the airway. There was no statistical difference between the two groups with regard to age. The duration of survival of patients with SCC of the airway from the first Nd:YAG laser treatment was determined. A significant difference between those patients treated with Nd:YAG laser alone and those patients treated with combined therapy was found (p<0.001). Brachytherapy may potentiate the duration of survival in patients with SCC involving the airway compared to palliation with Nd:YAG laser alone.",
author = "Shea, {J. M.} and Allen, {Roblee P} and Tharratt, {R. S.} and Andrew Chan and Siefkin, {A. D.}",
year = "1993",
language = "English (US)",
volume = "103",
pages = "1028--1031",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

TY - JOUR

T1 - Survival of patients undergoing Nd

T2 - YAG laser therapy compared with Nd:YAG laser therapy and brachytherapy for malignant airway disease

AU - Shea, J. M.

AU - Allen, Roblee P

AU - Tharratt, R. S.

AU - Chan, Andrew

AU - Siefkin, A. D.

PY - 1993

Y1 - 1993

N2 - Brachytherapy in combination with Nd:YAG laser therapy may add to the duration of survival of the palliative period when compared with laser alone. A retrospective study of patients with inoperable squamous cell carcinoma (SCC) was undertaken to determine if there was a difference in survival between those patients treated with Nd:YAG laser alone and those treated with Nd:YAG laser and brachytherapy. Twenty-two patients were treated with brachytherapy for malignant airway disease at our institution of which 13 had SCC. All patients had previously received treatment with Nd:YAG laser for exophytic disease. Survival was compared with those patients treated with Nd:YAG laser alone for SCC involving the airway. There was no statistical difference between the two groups with regard to age. The duration of survival of patients with SCC of the airway from the first Nd:YAG laser treatment was determined. A significant difference between those patients treated with Nd:YAG laser alone and those patients treated with combined therapy was found (p<0.001). Brachytherapy may potentiate the duration of survival in patients with SCC involving the airway compared to palliation with Nd:YAG laser alone.

AB - Brachytherapy in combination with Nd:YAG laser therapy may add to the duration of survival of the palliative period when compared with laser alone. A retrospective study of patients with inoperable squamous cell carcinoma (SCC) was undertaken to determine if there was a difference in survival between those patients treated with Nd:YAG laser alone and those treated with Nd:YAG laser and brachytherapy. Twenty-two patients were treated with brachytherapy for malignant airway disease at our institution of which 13 had SCC. All patients had previously received treatment with Nd:YAG laser for exophytic disease. Survival was compared with those patients treated with Nd:YAG laser alone for SCC involving the airway. There was no statistical difference between the two groups with regard to age. The duration of survival of patients with SCC of the airway from the first Nd:YAG laser treatment was determined. A significant difference between those patients treated with Nd:YAG laser alone and those patients treated with combined therapy was found (p<0.001). Brachytherapy may potentiate the duration of survival in patients with SCC involving the airway compared to palliation with Nd:YAG laser alone.

UR - http://www.scopus.com/inward/record.url?scp=0027457945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027457945&partnerID=8YFLogxK

M3 - Article

C2 - 7510598

AN - SCOPUS:0027457945

VL - 103

SP - 1028

EP - 1031

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -